Prostate Cancer Drug Development Summit
Evvnt Promotion / evvnt
17.08.2021 - 19.08.2021 Online
Time: 09:00 - 17:00
Temi della conferenza
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Speakers: Ellen Filvaroff, Bristol-Myers Squibb, Vivek Arora, Bristol Myers Squibb, Alison Crawford, Regeneron Pharmaceuticals, Inc, Maggie Janat-Amsbury, Amgen, Andrew Cavey, Novartis/Advanced Accelerator Applications and more.
Speakers: Ellen Filvaroff, Bristol-Myers Squibb, Vivek Arora, Bristol Myers Squibb, Alison Crawford, Regeneron Pharmaceuticals, Inc, Maggie Janat-Amsbury, Amgen, Andrew Cavey, Novartis/Advanced Accelerator Applications and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/757702-2?pid=4832
Ms. Jessica Durston
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
USD 1799.0 - USD 3297.0
USD 1799.0 - USD 3297.0
I partecipanti attesi
1000
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
